The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Encephalitis related to antibodies against the N-methyl-D-aspartate receptor (NMDAr) is a recently described clinical entity in which IgG autoantibodies against the NR1 subunit of the NMDAr lead to the appearance of complex neuropsychiatric symptoms.

 




Our findings suggest that 18F-FDG-PET should be included as an imaging tool when assessing affected patients in the clinical workup to rule out anti-NMDA encephalitis and help determine the most effective treatment.

 




In recent decades, neurology has evolved from localisation-based eponymous diagnoses
to molecular characterisation and classification. Neuroimmunology has received particular attention as many diagnostic mysteries have become answerable using an increasing array of IgG antibody diagnostic tests,…

 




Main menu Neurology.org JournalsNeurology Clinical Practice Genetics Neuroimmunology & Neuroinflammation Education Online SectionsNeurology Video Journal Club Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS) Innovations in Care Delivery Practice Buzz Practice Current Residents …

 




Anti-<i>N</i>-methyl-d-aspartate receptor (NMDAR) encephalitis is an immune-mediated disorder that typically presents with rapid development of neuropsychiatric symptoms.As a potentially reversible cause of psychosis, there have been calls internationally for routine serological screening for anti-…

 




Your donations enable our work. Please consider contributing today. https://www.antinmdafoundation.org/donate/